Jennifer Kim
Stock Analyst at Cantor Fitzgerald
(1.01)
# 2132
Out of 5,358 analysts
49
Total ratings
41.03%
Success rate
10.24%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BLTE Belite Bio | Reiterates: Overweight | n/a | n/a | n/a | 5 | May 15, 2025 | |
PGEN Precigen | Reiterates: Overweight | n/a | n/a | n/a | 4 | May 15, 2025 | |
INSM Insmed | Reiterates: Overweight | n/a | n/a | n/a | 8 | Feb 20, 2025 | |
FBIO Fortress Biotech | Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
EYPT EyePoint Pharmaceuti... | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 | n/a | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 1.06 | 88.68% | 2 | Aug 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 14 | 4.26 | 228.64% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 | 3.11 | 961.09% | 2 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 5 | 1.92 | 134.38% | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | n/a | n/a | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 220 100 | 2.02 | 4850.5% | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 56 | n/a | n/a | 2 | Mar 17, 2022 |